{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:45:27Z","timestamp":1776206727563,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":6931,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1023\/a:1008389706725","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"23-27","source":"Crossref","is-referenced-by-count":67,"title":["Retreatment of patients with the same chemotherapy: Implications for clinical mechanisms of drug resistance"],"prefix":"10.1016","volume":"12","author":[{"given":"S.","family":"Cara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.F.","family":"Tannock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008389706725_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00689638","article-title":"P-glycoprotein, multidrug resistance and tumor progression","volume":"13","author":"Bradley","year":"1994","journal-title":"Cancer Metast Rev"},{"issue":"Suppl","key":"10.1023\/A:1008389706725_bb0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s002800051053","article-title":"Multidrug resistance Molecular mechanisms and clinical relevance","volume":"40","author":"Ling","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1023\/A:1008389706725_bb0020","series-title":"The Basic Science of Oncology","first-page":"392","article-title":"Drug resistance and experimental chemotherapy","author":"Tannock","year":"1998"},{"key":"10.1023\/A:1008389706725_bb0025","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0002-9343(99)80285-X","article-title":"Clinical drug resistance The role of factors other than P-glycoprotein","volume":"99","author":"Kaye","year":"1995","journal-title":"Am J Med"},{"key":"10.1023\/A:1008389706725_bb0030","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1200\/JCO.1998.16.11.3674","article-title":"Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance","volume":"16","author":"Bradshaw","year":"1998","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"10.1023\/A:1008389706725_bb0035","first-page":"S15","article-title":"Multidrug resistance Clinical relevance in solid tumors and strategies for circumvention","volume":"10","author":"Kaye","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"10.1023\/A:1008389706725_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00296245","article-title":"Aspects of cytotoxic drug penetration, with particular reference to anthracychnes","volume":"19","author":"Kerr","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1023\/A:1008389706725_bb0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jnci\/81.2.146","article-title":"Distribution and activity of antineoplastic drugs in a tumor model","volume":"81","author":"Durand","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl II","key":"10.1023\/A:1008389706725_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)90327-0","article-title":"Conventional cancer therapy promise broken or promise delayed?","volume":"351","author":"Tannock","year":"1998","journal-title":"Lancet"},{"key":"10.1023\/A:1008389706725_bb0055","first-page":"1583","article-title":"Penetration of anticancer drugs through solid tissue A factor that limits the effectiveness of chemotherapy for solid tumors","volume":"5","author":"Tunggal","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1008389706725_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/030089169207800102","article-title":"Heterogeneity and phenotypic instability of chemotherapeutic and immunologic sensitivity in munne and human melanoma cell clones","volume":"78","author":"Supino","year":"1992","journal-title":"Tumon"},{"key":"10.1023\/A:1008389706725_bb0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnci\/86.13.975","article-title":"Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents","volume":"86","author":"Graham","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008389706725_bb0070","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0025-6196(12)62414-8","article-title":"Reinduction chemotherapy for acute nonlymphocytic leukemia","volume":"59","author":"Letendre","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1023\/A:1008389706725_bb0075","first-page":"184","volume":"4","author":"Hiddemann","year":"1990","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"10.1023\/A:1008389706725_bb0080","first-page":"143","article-title":"Retreatment with 2-CdA of progressed HCL patients","volume":"14","author":"Lauria","year":"1994","journal-title":"Leuk Lymph"},{"key":"10.1023\/A:1008389706725_bb0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10428199409051654","article-title":"Retreatment of chronic lymphocytic leukemia with 2-chlorodeoxyadenosine (CdA) at relapse following CdA-induced remission No acquired resistance","volume":"13","author":"Juliusson","year":"1994","journal-title":"Leuk Lymph"},{"key":"10.1023\/A:1008389706725_bb0090","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood.V51.6.1005.1005","article-title":"Unmantained remissions in multiple myeloma","volume":"51","author":"Alexanian","year":"1978","journal-title":"Blood"},{"key":"10.1023\/A:1008389706725_bb0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-90-5-761","article-title":"Prolonged disease-free survival in Hodgkin\u2019s disease with MOPP reinduction after first relapse","volume":"90","author":"Fisher","year":"1979","journal-title":"Ann Int Med"},{"key":"10.1023\/A:1008389706725_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.1994.12.1.45","article-title":"Reinduction with the same cytostatic treatment in patients with metastatic breast cancer An Eastern Cooperative Oncology Group study","volume":"12","author":"Falkson","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008389706725_bb0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1445-5994.1987.tb01225.x","article-title":"Chemotherapy for small-cell lung cancer Induction and reinduction with VOCA","volume":"17","author":"Stuart-Harris","year":"1987","journal-title":"Aust NZ J Med"},{"key":"10.1023\/A:1008389706725_bb0110","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0277-5379(87)90128-3","article-title":"Retreatment with the induction regimen in small-cell lung cancer relapsing after an initial response to short term chemotherapy","volume":"23","author":"Postmus","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1023\/A:1008389706725_bb0115","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/0277-5379(87)90452-4","article-title":"Reinduction chemotherapy in small-cell lung cancer","volume":"23","author":"Giaccone","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1023\/A:1008389706725_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/thx.47.5.369","article-title":"Treatment of relapse of small-cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide and epirubicin","volume":"47","author":"Collard","year":"1992","journal-title":"Thorax"},{"key":"10.1023\/A:1008389706725_bb0125","first-page":"188","article-title":"Paclitaxel retreatment in patients with platinum and paclitaxel resistant ovarian cancer","volume":"17","author":"Tresukosol","year":"1996","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1023\/A:1008389706725_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0090-8258(85)90249-5","article-title":"Recurrent ovarian carcinoma Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent","volume":"21","author":"Seltzer","year":"1985","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1008389706725_bb0135","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/bjc.1998.574","article-title":"Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer","volume":"78","author":"Hejna","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008389706725_bb0140","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/oxfordjournals.annonc.a058668","article-title":"Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer","volume":"4","author":"Kattan","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008389706725_bb0145","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/S0959-8049(97)10011-9","article-title":"Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy The International Breast Cancer Study Group","volume":"33","author":"Castiglione-Gertsch","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008389706725_bb0150","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1097-0142(19861001)58:7<1411::AID-CNCR2820580705>3.0.CO;2-G","article-title":"Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy","volume":"58","author":"Valagussa","year":"1986","journal-title":"Cancer"},{"key":"10.1023\/A:1008389706725_bb0155","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/1097-0142(19810615)47:12<2798::AID-CNCR2820471207>3.0.CO;2-T","article-title":"Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens","volume":"47","author":"Buzdar","year":"1981","journal-title":"Cancer"},{"key":"10.1023\/A:1008389706725_bb0160","first-page":"442","article-title":"Lung cancer","volume":"14","author":"Hansen","year":"1993","journal-title":"Cancer Chemother Biol Resp Modif"},{"key":"10.1023\/A:1008389706725_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"Mcguire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008389706725_bb0170","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.1987.5.12.1864","article-title":"Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung A randomized study","volume":"5","author":"Humblet","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008389706725_bb0175","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1200\/JCO.1998.16.6.2126","article-title":"Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer The Japan Clinical Oncology Group","volume":"16","author":"Furuse","year":"1998","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"10.1023\/A:1008389706725_bb0180","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1007\/s002800051063","article-title":"Importance of dose and dose intensity in the treatment of small-cell lung cancer","volume":"40","author":"Murray","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1023\/A:1008389706725_bb0185","first-page":"317","article-title":"Progress in chemotherapy for melastatic breast cancer","volume":"19","author":"Sledge","year":"1992","journal-title":"Sem Oncol"},{"key":"10.1023\/A:1008389706725_bb0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1200\/JCO.1983.1.1.2","article-title":"Adjuvant CMF in breast cancer Comparative 5-year results of 12 versus 6 cycles","volume":"1","author":"Tancini","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008389706725_bb0195","first-page":"26","article-title":"The effect of increasing dose intensity and cumulative dose of adjuvant cyclophosphamide in node positive breast cancer Results of NSABP B-25","volume":"46","author":"Wolmark","year":"1997","journal-title":"Breast Cancer Res Treat"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419472463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419472463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/1\/23\/19478588\/12-1-23.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T12:32:05Z","timestamp":1621081925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419472463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S0923753419472463"],"URL":"https:\/\/doi.org\/10.1023\/a:1008389706725","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}